Surgery for atrial fibrillation with radiofrequency ablation: four years experience
http://www.100md.com
《血管的通路杂志》
a Cardiac Surgery Department, Policlinico S. Orsola Malpighi, Bologna University, Bologna, Italy
b Cardiology Department, Policlinico S. Orsola Malpighi, Bologna University, Bologna, Italy
Presented at the 55th International Congress of the European Society for Cardiovascular Surgery, St. Petersburg, Russian Federation, May 11–14, 2006.
Abstract
Objective: Atrial fibrillation (AF) is very common in patients undergoing open heart surgery. AF ablation with different sources of energy, enables the surgeon to create linear lesions rapidly and safely. However, results of these technologies need examination. We report the clinical results obtained in a 4-year experience using mono- and bipolar radiofrequency (RF) ablation of AF in a heterogeneous group of 183 patients. Methods: From May 2001 until December 2005 a total of 183 patients underwent pulmonary vein isolation using RF energy. In 73 cases, monopolar RF was used. Energy was applied in the endocardium in 40 cases (Group A) and in the epicardium in 33 cases (Group B). From May 2003, bipolar RF was used in a total of 110 patients (Group C). Duration of AF, left atrial dimensions, age or reoperations, were not considered contraindications to ablation. Ablation procedure for AF ablation was associated with a variety of cardiac procedures, from isolated mitral valve procedure to complex ascending aorta operations. Results: In-hospital mortality was 3.8% in the whole group (range 2.7–6.1%). Mortality and morbidity were not related with the ablation procedure. At the follow-up time of 50.9±3.3, 48.2±3.1, 32.7±0.9 months (Group A, B and C, respectively), sinus rhythm (SR) is present in a percentage of 75%, 67.7%, 79.4% of patients. Higher incidence of AF recurrence occurred in the first six months after surgery in all three groups. Late recurrence was higher in the epicardial group and overall freedom of AF was 64% in Group A, 46% in Group B and 71.1% in Group C (P=0.01). Conclusions: Our results demonstrate that the epicardial monopolar RF ablation obtains worse results than the endocardial monopolar RF and the bipolar RF ablation. Bipolar RF theoretically grants transmurality and is easy and safe, and a complete ablation setting lines can be achieved. Bipolar RF enables extension of ablation to every patient on AF undergoing a cardiac operation.
Key Words: Atrial fibrillation; Radiofrequency ablation; Arrhythmia
1. Introduction
The Cox-Maze procedure is the most successful surgical treatment for atrial fibrillation (AF), eliminating the arrhythmia in more than 90% of patients [1,2]. This operation has not become popular due to its complexity and invasiveness.
In recent years, it has been of increasing interest trying to simplify this procedure, using new and different energy sources to create ablation lines. In the late 1990s, unipolar radiofrequency (RF) was introduced, obtaining rate of sinus rhythm (SR) restoration, ranging from 69% to 76.9% [3–5]. Many other authors have reported similar results using monopolar RF [6–8].
Unipolar RF applications have some limitations, such as high tissue temperature, resulting in neighboring mediastinal structure damage [9] and no predictable transmurality. Recently it has been demonstrated that narrow residual gaps may conduct AF, then transmural and complete lines of ablation must be created to guarantee total block [10]. Bipolar RF devices have been designed to ensure transmurality [11,12].
In this study we report and evaluate, retrospectively, the clinical results obtained in four years of experience surgically treating AF, in three different groups of patients: Group A using endocardial monopolar RF; Group B epicardial monopolar RF; and Group C, epicardial bipolar RF. The final purpose is to identify if BP RF is superior in terms of clinical results to the monopolar RF ablation. In other words if theoretical transmurality obtained with the use of BP RF corresponds with a higher incidence of SR restoration.
2. Materials and methods
Concomitant AF treatment with RF devices was performed in 183 patients between May 2001 and December 2005. In the first 40 cases, unipolar endocardial RF was used (Group A), while in 33 cases (Group B) unipolar RF was applied on beating heart in the epicardial surface. Bipolar RF ablation was performed in 110 patients, beginning in May 2003 (Group C).
Indications for ablation were permanent AF in 93.4% patients and persistent AF in 6.5%. Demographic and preoperative data are summarized in Table 1. Duration of AF, redo, low EF, advanced age or giant left atria were not considered as contraindications. The unique exclusion criterion was emergency surgery.
Surgical indications ranged from isolated mitral valve surgery to a very complex operation. Actually, in 70 patients (38.3%), the operations performed were complex procedures: pluri-valvular surgery, ascending aorta surgery, congenital cardiopathy, etc ... BP RF ablation was also performed in addition to ventricular resynchronization in two cases and, in one of them, to a Core-Cap device implantation plus mitral valve repair. Mitral valve repair was performed in 7.1% of patients. Ablation procedure was associated with 16 reoperations (8.7% from the overall groups, 7–17.5% in Group A, 1–30% in Group B, 8–7.3% in Group C).
Informed written consent was given by each patient.
2.1. Ablation procedure
Endocardial monopolar RF ablation (Group A) was performed in 40 patients. All ablations were performed using the Cobra system (Boston Scientific Corporation, San José, California). Ablation setting was 90 W RF power for 120 s. Once the heart was arrested and the left atriotomy achieved, a semicircular ablation line, in the endocardium, was performed to isolate the right pulmonary veins. Two lines around the left pulmonary veins were made. Both encirclings were connected with an ablation line in the posterior wall of the left atrium. A connecting line from the atriotomy to the mitral valve annulus was made.
Epicardial unipolar RF ablation (Group B) was performed in 33 patients. The device used was the same as previously described. Both right and left pulmonary vein encirclings were performed on beating heart on full cardiopulmonary bypass. The connecting line in between both encirclings was made in the left atrial roof through the transverse sinus. The connecting line to the mitral valve annulus was achieved in the endocardium when left atriotomy was performed. RF was delivered for 120 s at 90 W.
Bipolar RF ablation was used in 110 patients. The ablation system used was Cobra Bipolar system (Boston Scientific Corporation, San José, California) in 102 patients (98.2%), while in the remaining patients the Cardioablate BP (Medtronic Inc., Mineanapolis, USA) was utilized. The Cobra Bipolar ablation settings were 40 W for 40 s. The Cardioablate BP was applied for 16–17 s until the transmurality was reached. Temperature as well as power were autoregulated.
After dissection of the epicardial reflection, the bipolar device was clamped around the atrial cuff containing the right pulmonary veins. On cardiopulmonary bypass and on beating heart, the heart was lifted and the left pulmonary vein's encircling were performed. Both pulmonary vein ablations are repeated twice in order to avoid gaps. On cardioplegic arrest, the left atrial appendage (LAA) was opened and an additional ablation line connecting both encirclings in the transverse sinus was performed. The line toward the mitral annulus was performed from the LAA, or from the left atriotomy when achieved in cases of mitral valve surgery.
LAA was cut off in all 183 patients, and sutured from outside with a double suture of prolene 4/0. When giant left atria was present (defined as 60 mm of anteroposterior diameter) atrial reduction plasty was performed (58 patients–31.7% of the whole group, 15 patients–45% in Group A, five patients–15.2% in Group B, 35 patients–31.8% in Group C, P=0.001).
Conduction block validation was not achieved.
2.2. Perioperative management
Amiodarone intravenous administration started before the end of cardiopulmonary bypass at a dose of 300 mg and continued for 24 h at a dose of 900–1800 mg/24 h depending on the frequency. On the second postoperative day, 150–300 mg orally was prescribed. In the case of bradycardia or A–V block, amiodarone was avoided and pacing achieved.
Early electrical cardioversion (ECV) was performed in the case of AF maintenance or recurrence.
Warfarin was stopped after three months in cases of valve repair, bioprosthesis or CABG, when SR was documented.
All patients were re-examined at three, nine months and then yearly by standard 12-lead ECG and clinical examination.
2.3. Statistics
Continuous variables were normally distributed and described by arithmetic mean±S.D. Qualitative data were presented as absolute frequencies. Univariate analyses were performed for all relevant variables by means of chi-square for categorical variables and t-test for continuous variable. Multivariate analysis was performed for variable with a P-value>0.2. One way analysis of variance was used for group comparisons. Actuarial survival was estimated by Kaplan–Meier.
3. Results
The open heart procedures are detailed in Table 2.
Cardiopulmonary bypass time was 137.8±41 min (Group A), 128±30 min (Group B) and 125±40 min (Group C) (P=0.2). Cross-clamp time was 113±33.2 (Group A), 96.9±27.6 (Group B) and 94.9±32 (Group C) (P=0.01). These very long surgical times are perfectly justified, because of the complexity of the operations. Other surgical and postoperative data are shown in Table 3.
No complication related to the ablation procedure occurred (esophageal or bronchial tree injuries). Re-exploration for bleeding was required in 5.4% (10 patients). Median ICU and hospital stay days were 2 and 15 days, respectively.
Acute renal failure was present in 6.5% (12 patients).
In-hospital mortality in Group A was 5% (two patients). Causes of death were respiratory and liver insufficiency.
In Group B a total of two patients died (6.1%). Causes of death were tamponade (high INR7) and multiorgan failure.
Early mortality in Group C was 2.7% (three patients) and causes of death were cardicac failure, left ventricle rupture in a patient with massive calcifications of the mitral valve annulus and sepsis.
At arrival in the intensive care unit 82.5%, 81.9%, 90.9% (Group A, Group B, Group C, respectively) were on sinus rhythm. During the hospital stay, 27.8%, 41.4% and 31.7% patients (%) experienced recurrence of AF (Group A, Group B, Group C, respectively). ECV was performed in all these patients. At discharge, 25%, 15.2% and 5.5% of patients (Group A, Group B, Group C, respectively) (P=0.3) were on AF, independently of full admiodarone administration and ECV.
Late follow-up was achieved in all surviving patients with an overall follow-up time of 42.8±18.9 months in Group A, 32.5±14.1 months in Group B and 17.4±10 months in Group C.
Overall incidence of SR at the end of the follow-up is 75% in Group A, 67.7% in Group B, and 79.4% in Group C (P 0.01) (Fig. 1). Late AF recurrence was identified by ECG, and it occurred in: Group A 28.6%, Group B 41.9%, and Group C 15.7% (P (A–B)=0.3, P (A–C)=0.5, P (B–C)=0.08). Overall freedom of AF for all groups was 64.9%, 46% and 71.1%, respectively (P (A–B)=0.3, P (A–C)= 0.5, P (B–C)= 0.05) (Fig. 2). These are patients who have always been on sinus rhythm from the operation until the end of the follow-up.
Of patients on SR, 40.4% were not taking any antiarrhythmic drugs. One patient required catheter ablation for atypical atrial flutter (from Group B).
Most episodes of AF recurrence occurred in the first six months, decreasing in incidence with time with the exception of Group B, which presents a marked increase of episodes even after six months. The occurrence of AF was not influenced by any preoperative data with the exception of preoperative EF: when lower than 40% is related with lower probability of SR restoration and then a higher incidence of AF recurrence (P=0.03). Of all AF recurrences, only in two cases, patients were free of antiarrhythmic therapy (all from Group C).
Oral anticoagulation therapy (OAT) was stopped in a total of 35 patients, corresponding to the 39% of patients on SR and with tissue prosthesis, or valve repair, or CABG. Cumulative time without OAT is 23.9±15.8 months.
In the follow-up, five embolic events occurred, four TIA (all patients were on OAT, 50% of them were on AF and three had a tissue bioprosthesis) and one fatal ICTUS, one month after OAT suspension, in a patient on SR and with an aortic tissue valve.
In the follow-up, a total of 11.1% in Group A, 3.2% in Group B and 2.9% in Group C required pacemaker implantation because of atrio-ventricular block or extreme bradycardia (P (A–B)=0.5, P (A–C)=0.05, P (B–C)=0.2).
4. Discussion
This report documents the mid-term results obtained with the application of radiofrequency (RF) energy for atrial fibrillation (AF) ablation in cardiac surgical patients. Three groups are compared, depending on the type of device used: unipolar or bipolar, and the approach: endocardial or epicardial.
The rationale for restoring SR in patients undergoing cardiac surgery with concomitant AF includes (1) improving survival, (2) reducing the risk of thromboembolism, (3) eliminating the need for oral anticoagulation, (4) reducing symptoms associated with high heart rate, and (5) restoring atrial contraction and then improving cardiac output [13].
The Cox-Maze procedure has evolved to become the most successful surgical treatment for AF, but because of its complexity and invasiveness has not become popular among surgeons. Thanks to the increased understanding of pathogenesis of AF and development of new ablation technologies, a great interest in surgically curing AF has occurred. Many different sources of energy have been proposed and used in different ways. However, RF (either in the monopolar version, and most recently, in the bipolar version) is the most frequently used [3,6,14–23].
Different energy sources, different lesion sets, different types of patients and surgical indications, make it difficult to identify factors which influence the rate of success/failure [7,12,23,24].
In our department we have four years experience treating AF with different modalities of RF: monopolar RF applied in the endocardial surface (Group A), in the epicardial surface (Group B) and bipolar RF (Group C). The results obtained are analyzed and compared between groups.
Our results demonstrate that restoration of SR is particularly effective using the endocardial monopolar RF ablation and the bipolar RF ablation (75% and 79.4%, respectively), while with the epicardial monopolar RF ablation the SR rates obtained are significantly lower (67.7%, P=0.01). Moreover, the recurrence of AF, being higher in the first six months after the operation in all groups, has a greater incidence in the epicardial monopolar group. Our data document that the probability of SR restoration after AF recurrence is lower in the BP group, demonstrating that in those patients whom the procedure is not immediately successful, the risk of AF maintenance is higher. Those data, however, have no statistical significance.
In our experience, we have performed the ablation procedure to each patient undergoing a cardiac operation and suffering from AF (permanent or persistent). Long duration of atrial fibrillation, dimensions of left atrium, reoperations, old age, or low EF% have not been considered as contraindication, even if that decision may be arguable for many of our colleagues. Our results demonstrate that the only predictor factor of ablation failure is the low preoperative EF (<40%), with an incidence of ablation failure of 65.3% vs. 32.1% when EF is 40% (P=0.03). The other risk factors have been evaluated and no significant correlations have been found, and multivariate analysis has not been performed. Moreover, in cases of atriomegaly, a reduction plasty of the left atrium may help ablation effectiveness.
We did not report complications related to the ablation procedure such as esophageal injuries or bronchial tree, excluding a very low incidence of atrio-ventricular block, being significantly higher in the endocardial monopolar group. The incidence of atypical flutter was very low with only one case reported and successfully treated by previous mapping, with percutaneous ablation.
We agree with Benussi et al. [25] that the high rate of recurrence of AF and other supraventricular arrhythmias, most of them in the immediate postoperative period and in the first six months, justifies the routine use of antiarrhythmic drugs for at least six months after the operation. In some cases pharmacological cardioversion may not be sufficient and electrical cardioversion (ECV) must be performed. In our experience, the higher the incidence of AF recurrence in the first six months may be related to a main etiopathology: the lack of complete fibrosis of the lesion.
In accordance with the major experts in this field [13] the ablation pattern must include the lesion toward the mitral valve annulus, and it has been always included in our patients. In the BP group (Group C), the execution of this line may be difficult, since it can be insufficient and leave a gap or, contrary, damage the circumflex artery. Our results demonstrate that, when performed correctly, the ablation line is safe and effective.
The present paper has many limitations, first of all the retrospective analysis. The patient population is markedly heterogeneous, in terms of surgical indication and procedures. That demonstrates the feasibility of the ablation procedure with RF in all the three modalities, but, at the same time, the rate of SR restoration can be conditioned by the nature of the AF and the operation performed. Moreover, when talking about AF recurrence, this can be underestimated because of no ECG verification of asymptomatic episodes. More sophisticated statistical methods would be needed to correctly estimate AF events. Another limitation is that conduction block, by pacing the pulmonary veins, has not been assessed; it is therefore possible that some patients received incomplete lesions, contributing to ablation failures. Transmurality and completeness of the lesion are not assumed, and other pathology analyses as well as postoperative catheterism would be advisable to assess these two very important factors.
We can conclude that bipolar radiofrequency is effective in curing atrial fibrillation in more than 85% of patients. Even if similar results have been obtained with the endocardial monopolar RF ablation, the BP ablation is easier to perform, is not time consuming and has a lower incidence of atrio-ventricular block as well as lower incidence of AF recurrence. Moreover, the epicardial application of the BP device allows the surgeons to extend indication to all the patients on AF (either permanent, persistent or even paroxysmal) and undergoing cardiac surgery, even in complex operations. Our results demonstrate that RF can be performed even in cases of long duration of AF, giant atrium or reoperations. The worst results obtained with the epicardial monopolar approach, in spite of the initial enthusiasm, led us to abandon that approach.
References
Prasad SM, Maniar HS, Camillo CJ, Schuessler RB, Boineau JP, Sundt III, Cox JL, Damiano J. The Cox Maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003; 126:1822–1827.
Cox JL, Boineau JP, Schuessler RB, Ferguson TB, Cain ME, Lindsay BD, Corr PB, Kater KM, Lappas DG. Successful surgical treatment of atrial fibrillation. Review and clinical update. J Am Med Assoc 1991; 266:1976–1980.
Benussi S, Pappone C, Nascimbene S, Oreto G, Caldarola A, Stefano PL, Casati V, Alfieri O. A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach. Eur J Cardiothorac Surg 2000; 17:524–529.
Melo J, Adragao P, Neves J, Ferreira M, Timoteo A, Santiago T, Ribeiras R, Canada M. Endocardial and epicardial radiofrequency ablation in the treatment of atrial fibrillation with a new intra-operative device. Eur J Cardiothorac Surg 2000; 18:182–186.
Hindricks G, Mohr FW, Autschbach R, Kottkamp H. Antiarrhythmic surgery for treatment of atrial fibrillation—new concepts. Thorac Cardiovasc Surg 1999; 47:365–369.
Hornero F, Montero JA, Canovas S, Bueno M. Biatrial radiofrequency ablation for atrial fibrillation: epicardial and endocardial surgical approach. Interact CardioVasc Thorac Surg 2002; 1:72–77.
Mohr FW, Fabricius AM, Falk V, Autschbach R, Doll N, von Oppell U, Diegeler A, Kottkamp H, Hindricks G. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results. J Thorac Cardiovasc Surg 2002; 123:919–927.
Raman JS, Ishikawa S, Power JM. Epicardial radiofrequency ablation of both atria in the treatment of atrial fibrillation: experience in patients. Ann Thorac Surg 2002; 74:1506–1509.
Aupperle H, Doll N, Walther T, Kornherr P, Ullmann C, Schoon HA, Mohr FW. Ablation of atrial fibrillation and esophageal injury: effects of energy source and ablation technique. J Thorac Cardiovasc Surg 2005; 130:1549–1554.
Melby SJ, Lee AM, Zierer A, Boineau JP, Schuessler RB, Damiano J. Do surgical ablations have to be transmural to prevent the propagation of atrial fibrillation J Am Coll Surg 2005; 201:S23.
Prasad SM, Maniar HS, Diodato MD, Schuessler RB, Damiano J. Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study. Ann Thorac Surg 2003; 76:836–842.
Gillinov AM, McCarthy PM. Atricure bipolar radiofrequency clamp for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 2002; 74:2165–2168.
Gillinov AM, McCarthy PM, Blackstone EH, Rajeswaran J, Pettersson G, Sabik JF, Svensson LG, Cosgrove DM, Hill KM, Gonzalez-Stawinski GV. Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality. J Thorac Cardiovasc Surg 2005; 129:1321–1328.
Chiappini B, Martin-Suarez S, LoForte A, Di Bartolomeo R, Marinelli G. Surgery for atrial fibrillation using radiofrequency catheter ablation. J Thorac Cardiovasc Surg 2003; 126:1788–1791.
Chiappini B, Martin-Suarez S, LoForte A, Arpesella G, Di Bartolomeo R, Marinelli G. Cox/Maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation: a comparative study. Ann Thorac Surg 2004; 77:87–92.
Benussi S, Nascimbene S, Agricola E, Calori G, Calvi S, Caldarola A, Oppizzi M, Casati V, Pappone C, Alfieri O. Surgical ablation of atrial fibrillation using the epicardial radiofrequency approach: mid-term results and risk analysis. Ann Thorac Surg 2002; 74:1050–1057.
Deneke T, Khargi K, Grewe PH, von Dryander S, Kuschkowitz F, Lawo T, Muller KM, Laczkovics A, Lemke B. Left atrial versus bi-atrial maze operation using intraoperatively cooled-tip radiofrequency ablation in patients undergoing open-heart surgery: safety and efficacy. J Am Coll Cardiol 2002; 39:1644–1650.
Gaynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, Damiano NR, Bloch JB, Moon MR, Damiano J. A prospective, single-center clinical trial of a modified Cox Maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg 2004; 128:535–542.
Melo J, Adragao P, Neves J, Ferreira MM, Pinto MM, Rebocho MJ, Parreira L, Ramos T. Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year. Eur J Cardiothorac Surg 1999; 15:851–855.
Pasic M, Bergs P, Muller P, Hofmann M, Grauhan O, Kuppe H, Hetzer R. Intraoperative radiofrequency maze ablation for atrial fibrillation: the Berlin modification. Ann Thorac Surg 2001; 72:1484–1491.
Raman J, Ishikawa S, Power J. Surgical radiofrequency ablation of both atria for the treatment of atrial fibrillation—mid term results. Heart Lung Circulation 2003; 12:A28.
Sie HT, Beukema WP, Ramdat Misier AR, Elvan A, Ennema JJ, Wellens HJJ. The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery. Eur J Cardiothorac Surg 2001; 19:443–447.
Sie HT, Beukema WP, Elvan A, Ramdat Misier AR. Long-term results of irrigated radiofrequency modified maze procedure in 200 patients with concomitant cardiac surgery: six years experience. Ann Thorac Surg 2004; 77:512–517.
Damiano J, Gaynor SL, Bailey M, Prasad S, Cox JL, Boineau JP, Schuessler RP. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. J Thorac Cardiovasc Surg 2003; 126:2016–2021.
Benussi S, Nascimbene S, Calori G, Denti P, Ziskind Z, Kassem S, La Canna G, Pappone C, Alfieri O. Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device. J Thorac Cardiovasc Surg 2005; 130:491–497.(Sofìa Martìn-Suàreza,, Barbara Claysseta)
濠电姷鏁告慨鐑藉极閸涘﹥鍙忛柣鎴ｆ閺嬩線鏌熼梻瀵割槮缁炬儳娼￠弻鐔衡偓鐢登瑰瓭缂備浇缈伴崐婵嬪蓟閿曗偓铻ｅ〒姘煎灡閿涘棗鈹戦悙鍙夆枙濞存粍绻堝畷鎴﹀箛閻楀牆浠梺鎼炲労娴滄粓鎯冮悜妯镐簻闁挎棁顕ч獮鏍煃鐟欏嫬鐏撮柟顔规櫇缁辨帒螣婵犳碍鏆樺┑鐘垫暩閸嬫盯鎯囨导鏉戠９婵犻潧顑冮埀顑跨椤繈鎳滈悽闈涘Ц闁诲骸绠嶉崕鍗炍涘☉銏犲偍闁告鍋愰弨浠嬫煟閹邦厽缍戦柣蹇嬪劤閳ь剝顫夊ú锕傚礈閻斿鍤曢柟闂寸鍥撮梺绯曞墲閸旀帞鑺辨繝姘拺闁告劕寮堕幆鍫ユ煕閻曚礁浜扮€规洏鍨介獮姗€顢欓悾灞藉箰闂佽绻掗崑娑欐櫠娴犲鐓″鑸靛姈閻撳啴鏌﹀Ο渚▓婵☆垪鍋撻柣搴ゎ潐濞测晝鎹㈠┑瀣畺婵炲棗娴氶崯鍛亜閺傚墽鐭欓柣娑橀叄濮婂宕掑▎鎴М闂佸湱鈷堥崑濠呮濡炪倖鍔х粻鎴︽偪閻愵剛绡€濠电姴鍊搁幃鈺傜箾閹存瑥鐏╃紒鈧崘鈹夸簻闁哄啫娲らˉ宥夋煙閼恒儲绀€闁宠鍨块幃娆撳级閹寸姳妗撻梺鑹帮骏閸婃繈寮婚敍鍕ㄥ亾閿濆簼閭柛娆忓閺岋綁骞欓崘銊ゅ枈閻庤娲栭悥鍏间繆閹间焦鏅濋柍褜鍓熼幆鍐箣閿旇В鎷虹紓浣割儐椤戞瑩宕曢幇鐗堢厵婵繂鑻崥鍦磼椤旂⒈鍎旀鐐村浮瀵剟宕崟顏勵棜闂備焦瀵х换鍌滆姳閼测晞濮冲ù鐘差儐閻撴洟鏌￠崘鈺傚暗闁伙綀椴搁妵鍕敂閸曨偅娈绘繝纰樷偓宕囧煟鐎规洖宕灃闁逞屽墮宀ｅ潡骞嬮敂瑙ｆ嫼缂備礁顑嗛娆撳磿閹扮増鐓欓柣鐔哄閸犳ḿ鈧鍠涢褔鍩ユ径鎰潊闁炽儱鍘栧Ч妤呮煟鎼淬値娼愭繛鍙夌墪鐓ら柕蹇嬪€曢悞鍨亜閹哄秶顦︾紒妤佽壘鑿愰柛銉戝秷鍚悗瑙勬穿缁叉儳顕ラ崟顒傜瘈闁稿被鍊栫紞瀣⒒閸屾瑧顦﹂柣銈呮喘閿濈偞寰勯幇顒€鐎梺鍓茬厛閸犳岸寮抽敃鍌涚厱妞ゆ劧绲剧粈鈧梺缁樻尰閿曘垽寮婚敐澶婄疀闂傚牊绋戦～顐ｇ箾鐎涙ḿ鐭嬮柣鐔叉櫅椤繘鎼圭憴鍕彴闂佸搫琚崕娲焵椤掍緡娈樼紒杈ㄥ浮閹晠鎳犻顐庡應鍋撶憴鍕婵炶尙鍠庨悾鐑芥晸閻樺啿鈧鈧箍鍎卞Λ娑㈠煡婢舵劖鐓冮柦妯侯樈濡偓婵犳鍠掗崑鎾绘⒑缂佹﹫鑰挎繛浣冲嫭鍙忛柨鏃€鍨濈换鍡涙煟閹板吀绨婚柍褜鍓氶悧婊堝极椤曗偓楠炴帒顪冨┑鍡樺枠妞ゃ垺鐩幃娆撳级閹存柨浜鹃柛顐ｆ礃閻撱儵鏌￠崘銊モ偓濠氬箺閸屾稓绠鹃柛顐ｇ矌閻瑩鏌″畝瀣М妤犵偛娲、妤佹媴閸欏浜為梻鍌欒兌鏋悗娑掓櫅椤繗銇愰幒瀣у亾閸愵喖唯闁冲搫鍊搁埀顒傚厴閺屾稑鈻庤箛锝喰﹂梺鍝勵儑婵挳鈥旈崘顔嘉ч柛鎰╁妿娴犳儳鈹戦埥鍡椾簻闁哥噥鍋婇幃楣冩倻閽樺）鈺呮煃閸濆嫸鏀婚柡鍜冪秮濮婅櫣绱掑Ο鍝勵潚濠电偘鍖犻崶褏顔愮紓浣割儏缁ㄩ亶寮ㄦ禒瀣厽婵☆垵娅ｆ禒娑㈡煛閸″繑娅婇柡灞剧〒閳ь剨缍嗛崜娆撳煝閸噥娈介柣鎰摠瀹曞本銇勯姀鈩冾棃鐎规洖宕灃闁告劦浜為幗宀勬⒒閸屾瑦绁版い鏇熺墵瀹曡绺介崨濠傗偓鍫曟煙闁箑鍔掓繛宸憾閺佸倿鏌涢弴銊ュ季闁告艾鎳樺缁樻媴閾忕懓绗￠梺鎸庡哺閺屾稑顫濋敐鍛缂傚倸鍊烽悞锕傘€冮崨姝ゅ洭妫冨☉杈ㄧ稁濠电偛妯婃禍婊呯不娴兼潙绠归弶鍫濆⒔閹ジ鏌ｉ敐鍥ㄦ毈婵﹥妞介幃鐑藉级閹稿巩鈺侇渻閵堝棗鐏ユい锔诲灦閹箖鎮滈懞銉ヤ缓缂備礁顑呭ḿ锟犲船鐠鸿 鏀介柣姗嗗枛閻掑搫霉濠婂嫮绠撻摶鐐烘煕閹伴潧鏋涢柡瀣╃窔閺屾稓浠﹂崜褏鐓傛俊鐐额潐婵炲﹪骞冨Δ鍛櫜閹煎瓨绻勯惄搴㈢節绾版ǚ鍋撻悙钘変划濠殿喖锕︾划顖炲箯閸涙潙宸濆┑鐘插暙閺嬫垿姊绘担鍛靛綊顢栭崶顒€纾婚柕鍫濐槺瀹撲線鏌熼悧鍫熺凡缂佺媭鍣ｉ弻锕€螣娓氼垱歇闂佺濮ゅú鐔奉潖濞差亜浼犻柛鏇ㄥ墮閸嬪秹姊洪幖鐐插缂傚秴锕幃浼搭敋閳ь剚鎱ㄩ埀顒勬煏閸繃顥犻柛妯绘倐濮婃椽骞栭悙鎻掑闂佸搫鎳忕粙鎴︽偤椤撶偐鏀介柣妯活問閺嗩垶鏌嶈閸撴繄浜稿▎鎾村剹婵炲棙鎸婚悡娑氣偓鍏夊亾閻庯綆鍓涜ⅵ濠电姵顔栭崰鎺楀磻閹剧粯鈷戦悗鍦У閵嗗啴鏌ょ€圭姴鐓愮紒鍌涘浮閸╋繝宕橀鍡闯闂備胶枪閺堫剙顫濋妸銉ф懃闂傚倷鐒︾€笛兠洪敂鐣岊洸妞ゅ繐鐗婇崑妯汇亜閺冨倹娅曠紒鈾€鍋撻梻浣规偠閸庮垶宕濆鍛瀺闁靛繈鍊栭埛鎴犵磽娴ｅ箍鈧帡宕烽婵堝墾濠电偛妫欓幐濠氬磻椤忓牊鐓冪憸婊堝礈濮橆厾鈹嶅┑鐘叉处閸婇攱銇勮箛鎾愁仱闁稿鎹囧浠嬵敇閻愭鍞跺┑掳鍊х徊浠嬪疮椤愩倕顥氬┑鐘崇閻撶喖鏌￠崒娑橆嚋闁规彃鎲￠妵鍕煛閸愩劌骞嬮梺鍝勭灱閸犳牠鐛澶樻晩缁炬媽椴稿В澶愭⒒娴ｇ懓鈻曢柡鈧柆宥呭瀭闁秆勵殔閽冪喐绻涢幋娆忕仾闁哄懏绮撻幃褰掑炊閵娿儳绁风紓浣诡殔閻倸顫忓ú顏呭殥闁靛牆鎳忛悗楣冩⒑闂堚晝绋绘繛鍏肩懅閸欏懎顪冮妶鍛閻庢埃鍋撻悷婊勬瀵鈽夐姀鐘栥劍銇勯弮鈧崕宕囨暜閵夈儮鏀介柣鎰硾娴滃綊鏌涢悩宕囧ⅹ妞ゎ偄绻愮叅妞ゅ繐瀚ˇ銊╂⒑閸涘﹦鎳冩い锔垮嵆瀹曟洟骞樼紒妯锋嫼闂佽崵鍠愬姗€寮虫潏銊﹀弿婵鐗嗛々顒勬煙楠炲灝鐏╂い顐ｇ箞閹虫粎鍠婂Ο璇差伜婵犵數鍋犻幓顏嗗緤娴犲绠犳繛鍡樺竾娴滃綊鏌熼悜妯虹仴闁绘繃锚椤啴濡堕崱妤冪懆闂佺ǹ锕ら…鐑藉箚鐏炶В鏋庨柟鎯ь嚟閸樼敻姊虹紒妯虹仸闁挎洍鏅涢埢鎾诲即閵忥紕鍘辨繝鐢靛Т閸婄粯绂掑☉銏＄厪闁搞儜鍐句純閻庢鍣崜鐔风暦瑜版帩鏁婇悷娆忓閻﹁京绱撻崒娆掑厡闁稿鎹囧畷鏇㈠箮閽樺）褔鏌熼梻瀵割槮闁藉啰鍠栭弻銊╂偄閸濆嫅銏㈢磼閳ь剟宕橀鐣屽帾婵犵數鍋涢悘婵嬪礉濡ゅ懏鐓曢悗锝庡亝鐏忕數绱掗鐣屾噰妤犵偞鍔栭幆鏃堝閵忊槅娼犳繝鐢靛Х閺佸憡鎱ㄩ悜钘夋瀬闁告稑锕ラ崣蹇斻亜閹惧崬鐏╃紒鐙€鍨堕弻娑㈠箛闂堟稒鐏堢紓浣插亾閻庯綆鍠楅悡鏇熴亜椤撶喎鐏ュù婊呭仱閺屸剝寰勬繝鍕ㄩ梺鍝勭焿缁查箖骞嗛弮鍫濐潊闁宠桨鐒﹀▍娑㈡⒒娴ｅ憡鎲稿┑顔炬暬閹囨偐鐠囪尙鐣洪梺闈涱槴閺呮粓宕戦崒鐐茬閺夊牆澧界粙缁樼箾閸喎鍔ら柍瑙勫灴椤㈡瑦鎱ㄩ幇顏嗘崟闂備胶枪椤戝棝骞愰幖浣哥厴闁硅揪绠戦悞娲煕閹板吀绨奸柟鍙夌懃椤啴濡惰箛娑欘€嶆繝鐢靛仜閿曨亜顕ｇ拠娴嬫闁靛繒濮烽鎺楁⒑閸濆嫷妲归柛銊潐缁傛帡宕妷褏锛濇繛杈剧秬濞咃絿鏁☉姘辩＜閻庯綆鍋呭畷宀勬煕閳规儳浜炬俊鐐€栫敮濠囨嚄閸洖鐓€闁哄洨鍋熼弳鍡涙煥濠靛棙鍣洪柛瀣ㄥ劦閺岀喖顢涘顓熸嫳缂備胶绮换鍫濈暦閹达附鍤嶉柕澶涘瘜濡啴姊虹拠鈥虫灀闁哄懐濮撮悾鐑芥晲閸℃绐為柣搴秵娴滄繈鎮楁ィ鍐┾拻闁稿本鐟︾粊鐗堜繆濡炵厧濡挎繛鍡愬灲閺佹捇鎮╅弻銉︼紬闂備焦瀵х换鍌炈囬銏犵劦妞ゆ垼娉曠粣鏃傗偓娈垮枟閹歌櫕鎱ㄩ埀顒勬煃閳轰礁鏆為柣婵囨礋濮婄粯鎷呴挊澹捇鏌ㄥ顓滀簻闁挎棁娉曢惌娆撴煕閳规儳浜炬俊鐐€栫敮濠囨嚄閸洖鐓″鑸靛姈閻撳啴鎮峰▎蹇擃仼闁诲繑鎸抽弻鈩冩媴閸濄儛褏鈧娲滈崰鏍€侀弴銏℃櫖闁告洦鍓欑粈瀣攽閻樺灚鏆╁┑顕呭弮楠炲繘宕橀鐓庣獩濡炪倖姊婚弲顐ャ亹瑜忕槐鎾诲磼濞嗘垼绐楅梺鍝ュУ椤ㄥ﹪骞冮悜鑺ユ櫆闁绘劦鍓欐惔濠傗攽閻樼粯娑фい鎴濇嚇閹瑦绻濋崶銊у帾婵犵數鍊崘銊︽缂備胶濮锋晶妤冩崲濠靛鍋ㄩ梻鍫熷垁閻愮儤鐓曢柕濞у啫浠橀梺宕囩帛閺屻劑鍩ユ径鎰潊闁斥晛鍟悵鏍⒒娓氣偓濞佳囨偋閸℃蛋鍥敍濮ｅ灕鍥ц摕闁靛濡囬崢鎼佹⒑閹肩偛鍔楅柡鍛洴瀵悂骞嬮敂鐣屽幈濠电偛妫楃换鎺旂不婵犳碍鐓涚€光偓鐎ｎ剛袦闂佽鍠撻崹浠嬪箖閳╁啯鍎熸繝闈涙閻庡啿鈹戦悩娈挎毌婵℃彃鎳樺畷褰掝敂閸繄锛涢梺鐟板⒔缁垶鍩涢幒鎳ㄥ綊鏁愰崼婢捇鏌曢崱妤€鏆熺紒杈ㄥ浮閸┾偓妞ゆ帊鐒︽刊鎾煣韫囨挻璐￠柣鎾愁儔濮婃椽宕烽鈩冾€楅梺鍝ュУ椤ㄥ﹤鐣烽幋锕€鐓涢柛灞剧矌閻﹀牓姊婚崒姘卞濞撴碍顨婂畷鏇＄疀閺囩姷锛滈梺閫炲苯澧寸€规洘锕㈤崺鐐村緞閸濄儳娉垮┑锛勫亼閸婃牠骞愭ィ鍐ㄧ獥閹兼番鍔嶉崐鍫曟煥濠靛棭妲归柣鎾寸懇閹鎮介惂璇茬秺瀹曘垻鈧稒蓱閸欏繐鈹戦悩鎻掝伀閻㈩垱鐩弻鐔风暋閻楀牆娅х紓渚囧枤閺佹悂鍩€椤掑﹦绉靛ù婊勭箞閹偓瀵肩€涙ǚ鎷绘繛杈剧到閹诧繝骞夌粙搴撴斀妞ゆ梻鍋撻弳顒侇殽閻愭潙鐏寸€规洘鍎奸ˇ鎾煛閸☆參妾紒缁樼箞濡啫鈽夐崘鎻掝潬闂備焦鐪归崐鎰板磻閹惧绡€闁汇垽娼ф禒锕傛煕閵娿儱鎮戦柕鍥ㄦ楠炴牗鎷呴崫銉︾叄闂備焦瀵х换鍌毭洪妸褍顥氬ù鐘差儐閻撴洟鎮橀悙鎻掆挃闁瑰啿鎳橀弻娑㈠棘鐠恒剱銏ゆ煟閿濆棛绠為柡浣瑰姍瀹曘劑顢欓梻瀛樻▕闂傚倷鑳剁涵鍫曞棘閸岀偛鍨傞柦妯侯樈閸ゆ洘銇勯弴妤€浜鹃悗瑙勬礀閵堟悂骞冮姀銈呬紶闁告洦鍋嗛鎴︽⒒閸屾艾鈧兘鎳楅崼鏇炵疇闁圭偓妞块弫瀣亜閹惧崬鐏╃痪鎯ф健閺岀喓鈧數枪娴犙囨煟閻旀椿娼愮紒缁樼洴楠炲鈻庤箛鏇氱棯闂備胶绮幐璇裁洪悢鐓庤摕闁跨喓濮寸壕鍏兼叏濡搫缍侀柧蹇撻叄濮婃椽宕崟顒婄川缂傚倸绉崇欢姘嚕婵犳艾鐏崇€规洖娲﹀▓鏇㈡煟鎼搭垳绉甸柛鎾寸洴閹線宕奸妷锕€鈧敻鎮峰▎蹇擃仾缂佲偓閸愵喗鍋ㄦい鏍ㄧ☉濞搭噣鏌ㄥ┑鍫濅粶闁宠鍨归埀顒婄到閻忔岸寮查敐澶嬧拺缂備焦锕懓鎸庣箾娴ｅ啿娲ㄥ畵渚€鏌嶈閸撴稓妲愰幘璇茬＜婵﹩鍏橀崑鎾诲箹娴ｅ摜锛欓梺缁樺灱婵倝宕愰崸妤佺叆闁哄洨鍋涢埀顒€鐖奸崺鈧い鎺嗗亾闁哥喐娼欓悾鐑藉Ω閵夘喗妗ㄩ梺闈涚墕閹冲繘宕板鈧弻锛勪沪閼恒儺妫炲銈嗘尭閵堢ǹ鐣烽妸鈺婃晬婵﹩鍎烽弴鐐╂斀闁挎稑瀚禍濂告煕婵犲啰澧遍柡渚囧櫍楠炴帒螖閳ь剛绮ｅΔ浣瑰弿婵妫楅崢宕囩磽閸屾稑鍝洪柡宀€鍠栭弻鍥晝閳ь剟寮搁妶鍥╂／闁诡垎鍐╁€梺闈涙搐鐎氭澘顕ｉ鈧畷鎯邦槺婵顨堢槐鎾存媴閸濆嫅銏°亜椤撶姴鍘寸€殿喖顭锋俊鎼佸Ψ閵忊剝鏉搁梻浣稿閸嬪懐鎹㈤埀顒佷繆閸欏濮嶆慨濠勫劋濞碱亪骞嶉鍛滈梻浣告憸閸犳劕岣垮▎鎾村仼闁绘垼妫勭粻鎶芥煙閹碱厼骞楅柛宥囨暬濮婃椽宕ㄦ繝搴㈢暭闂佺ǹ顑囬崑銈夌嵁婢舵劕顫呴柕鍫濇閹风粯绻涙潏鍓хК婵☆偄瀚板畷銉╂偡閹佃櫕鏂€闂佺粯鍔忛弲娑欑閸撗呯＝闁稿本鑹鹃埀顒佹倐瀹曟劘銇愰幒鎾虫疄婵°倧绲介崯顐︽偂濠靛牃鍋撻獮鍨姎妞わ缚鍗冲鏌ュ蓟閵夛妇鍘遍梺闈涱槶閸ㄥ搫鈻嶉崶顒佺厽闁圭偓鍓氶崕鏃€鎱ㄦ繝鍐┿仢鐎规洘绮撻幊鐘活敆閳ь剛鏁妷鈺傗拺闁告縿鍎辨牎闂佸湱鎳撳ú顓炵暦濞差亜鐒垫い鎺嶉檷娴滄粓鏌熼崫鍕ゆい锔煎缁辨帒螖娴ｅ摜鐟查梺闈涙搐鐎氫即銆侀弴銏℃櫜闁搞儮鏅濋弶鑺ヤ繆閻愵亜鈧垿宕瑰ú顏呮櫇闁靛繈鍊曠粻鏍煃閸濆嫭濯奸柡浣稿暣閺屻劌鈹戦崱妤婂妷缂傚倸绉撮惌鍌氼潖婵犳艾纾兼慨姗嗗厴閸嬫挻顦版惔銏╁仺濠殿喗锕╅崗妤冪磽濮樿鲸鍠愮€广儱娲ゅ鏌ユ⒒娓氣偓濞佳囨偋閸℃稑绠栭柛顭戝晹濞差亶鏁傞柛鏇炵岸閺呯娀寮诲鍡樺闁瑰嘲鑻崢锟犳⒑閸涘﹥顥栫紒鐘冲灴閳ユ棃宕橀鍢壯囨煕閳╁喚娈橀柣鐔村姂濮婅櫣绮欏▎鎯у壈濠碘槅鍋呯换鍌烆敋閿濆惟闁冲搫鍊告禍閬嶆⒑閸撴彃浜栭柛銊ヮ煼椤㈡瑩寮撮悢铏圭槇闂侀潧楠忕徊鍓ф兜閻愵兙浜滈柟瀛樼箖閹兼劙鎮￠妶澶嬪€甸柣銏㈡暩閵嗗﹪鏌涚€ｎ偅灏甸柟鍙夋尦瀹曠喖顢楅崒锔惧枠闂傚倷鐒﹂幃鍫曞礉韫囨梹鍙忛柕鍫濇閳瑰秴鈹戦悩鍙夋悙闂佸崬娲弻锟犲炊閳轰椒鎴烽梺绋匡功閸嬨倕顫忓ú顏咁棃婵炴番鍔岀紞濠傜暦閺囥垺鍊绘俊顖欒閸ゃ倝姊洪崫鍕偍闁搞劍妞介幃锟犳偄閸忚偐鍘介梺鍝勫€圭€笛囧箟閹间焦鐓熸い鎾跺仩鐎氱増銇勯鈥冲姷妞わ箒娅曢妵鍕Ω閵壯冣叺閻庢鍣崑濠囥€佸▎鎾冲簥濠㈣泛顑嗛ˉ鍫⑩偓瑙勬处娴滎亜鐣峰鈧、鏃堝幢韫囨棑绱欐繝鐢靛Х閺佸憡鎱ㄦ导鏉戝瀭濠靛倻枪閺勩儵鏌″搴″箹缂佲偓婢舵劖鐓涚€广儱楠搁獮鏍棯閹岀吋闁哄被鍔岄埞鎴﹀幢閳哄倐褔姊虹紒妯诲鞍婵炶尙鍠栧濠氬即閻旈绐炲┑鈽嗗灥濞咃絾绂掗埡渚囨富闁靛牆鍊瑰▍鎾绘煕閹惧鎳囬柛鈹垮劜瀵板嫰骞囬鍌ゅ晪闂備浇宕甸崰鎰珶閸℃ぅ鎺楀閵忋垻锛濇繛杈剧导缁瑩宕ú顏呭仺妞ゆ牗渚楀▓鏂跨暆閿濆牆鍔电紒鐘崇☉閳藉螣濠х偓娅囬柟鍙夌摃缁犳稑鈽夊▎蹇庢偅濠电娀娼ч崐鎼佸箟閿熺姴鐓曢柟瀵稿У閸犳劙鏌ｅΔ鈧悧鍡樼┍椤栨稐绻嗘い鎰剁到閻忋儵鏌嶇憴鍕伌闁诡喗鐟╅崺鈩冩媴瀹勯偊妫滈梻鍌氬€搁崐宄懊归崶顒夋晪闁哄稁鍘肩粣妤佷繆閵堝懎鏆欓柛銊︾箞閺岀喖骞戦幇闈涙缂備胶濮靛姗€鍩為幋锔藉亹闁圭粯甯楀▓顓犵磽娴ｇǹ顣抽柛瀣洴閳ワ妇鎹勯妸锕€纾梺鎯х箰濠€杈ㄥ閸パ€鏀芥い鏃傘€嬮崝鐔兼煕鐎ｎ偅灏甸柟骞垮灩閳规垹鈧綆鍋勬禒娲⒒閸屾氨澧涚紒瀣姉閸掓帞鎹勬笟顖涘瘜闂侀潧鐗嗗Λ娆愬緞閸曨垱鐓曟俊顖氭贡閻瑦顨ラ悙鑼ⅵ濠碘剝鎮傞弫鍌炲传閸曨亞鍑归梻鍌欑閹诧繝宕濋幋锕€绀夌€广儱鎲橀敐澶樻晢闁告洦鍏橀幏娲⒑閸涘﹦绠撻悗姘煎櫍閸┿垺寰勯幇顓犲幈濠碘槅鍨辨禍浠嬪磻閵忊懇鍋撶憴鍕缂傚秴锕ら悾鐑藉箳濡や礁鈧兘鎮楅悽鐧诲湱鏁幆褉鏀介柣妯虹仛閺嗏晠鏌涚€ｎ剙鏋涚€规洘鍨块獮姗€寮妷锔锯偓娲⒑缁洖澧茬紒瀣浮閹繝寮撮姀鈥斥偓鐢告煥濠靛棗鏆欏┑锛勫帶閳规垿鍨鹃悙钘変划濠碘槅鍋傞悞锕€顕ラ崟顖氱疀妞ゆ挾濮村铏節閻㈤潧鈻堟繛浣冲吘娑樷枎閹炬娊妫烽悷婊呭鐢鎮″☉銏＄厱闁斥晛鍟伴幊鍐煛鐎ｎ偄鐏ラ懣鎰版煕閵夋垵绉烽崥顐㈩渻閵堝啫鐏紒瀣灴閿濈偛鈹戠€ｎ亞顢呴梺缁樺姀閺呮稑顕ュ鍛斀闁绘ɑ鍓氶崯蹇涙煕閻樺磭澧甸柡浣稿暣婵＄兘濡烽钘夌槣濠电偛顕慨鎾敄閸愵喖鐒垫い鎴ｆ硶缁愭梻鈧鍠楅幐铏叏閳ь剟鏌嶉埡浣告殲闁绘繃濞婂缁樻媴閾忓箍鈧﹪鏌涢幘瀵哥疄闁诡喚鍏橀弫鍐磼閵堝棙娅嶅┑鐘垫暩婵數鍠婂澶婄厱闁圭儤鍤氳ぐ鎺撴櫜闁割偆鍣ユ禒鈺呮煟閵忊晛鐏￠柣鈺婂灦瀵鎮㈤崫鍕€抽梺鍛婎殘閸嬫ḿ鑺辨禒瀣拺闁荤喐澹嗛悾顓㈡煕閵娿儳绉洪柛鈺冨仱楠炲鎮╅顫闂佹寧绻傛鍛婃櫠椤斿墽纾煎〒姘功閻ｇ敻鏌″畝瀣ɑ闁诡垱妫冮、娑樷堪閸涘拑缍佸娲传閵夈儛锝夋煟濡や胶鐭岄柛鎺撳笚缁绘繂顫濋鐔哥彸闂備胶纭堕崜婵嬫偡瑜旈幆渚€宕奸悢铏圭槇闂佹眹鍨藉ḿ褍鐡梻浣呵归敃銉╁箖閸岀偑鈧線寮崼顐ｆ櫇闂佹寧姊婚弲顐﹀储閻㈠憡鈷戦柛婵嗗閸庢盯鏌涚€ｎ亜顏柟渚垮姂瀹曟帒鈽夊▎蹇撲紟濠电姷鏁告慨鎾疮椤栫偛桅婵犻潧娴傚▓浠嬫煟閹邦厽缍戝┑顔肩墦閺岀喖顢涘☉娆樻闂佽桨鐒﹂崝娆忕暦閹烘垟妲堥弶鍫涘妿缁夐箖姊婚崒姘偓鎼佸磹妞嬪海鐭嗗〒姘ｅ亾妤犵偞鐗犻、鏇㈡晜閽樺缃曟繝鐢靛Т閿曘倝鎮ч崱娆戠焼闁割偁鍎查悡鐔兼煛閸愩劎澧辨俊顐ｅ灴閺岋繝宕遍鐘垫殼闂佸搫鐭夌紞渚€骞冮姀銏㈢煓婵炲棛鍋撻ˉ鎾绘⒒娴ｇǹ顥忛柛瀣笚缁傚秹顢旈崼婵婃憰濠电偞鍨崹褰掑础閹惰姤鐓忓┑鐐茬仢閸旀岸鎮楀☉宕囧埌闁宠鍨块幃娆戔偓娑欋缚缁嬪洭鏌ｆ惔銏犲毈闁告挾鍠栭崹楣冨籍閸繄顦ㄥ銈嗘煥濡插牐顦归柡灞剧洴閸╁嫰宕橀悙顒傛毉闂備浇宕甸崰鎰板礉濞嗗浚娼栭柧蹇撴贡绾惧吋淇婇娑欍仢闁搞倕顑囩槐鎾存媴閸濆嫅锝夋煙閸涘﹥鍊愭い銏″哺閺佹劖寰勬繝鍕靛敶缂傚倷鐒︾粙鎴︻敄閸℃稑鐤炬繝濠傜墛閳锋垿鏌涢幘鏉戠祷濞存粎鍋ら弻娑㈡偐閾忣偄纾抽悗瑙勬磸閸ㄤ粙寮婚崱妤婂悑闁糕€崇箲鐎氬ジ姊绘担钘夊惞闁哥姵鎸婚弲璺何旈崨顓犵暰闂佸壊鍋侀崹鑽ゅ閻撳寒鐔嗛悹杞拌閸庢劗绱撳鍡楃伌闁哄矉缍侀弫鎰板炊閵婏附鐦撻柣搴ゎ潐濞叉牕鐣烽鍕叀濠㈣泛艌閺嬪酣鏌熺€涙ḿ绠撶紒妤佸哺濮婃椽鎳￠妶鍛€剧紓渚囧枛缁夊爼宕氶幒妤€绠荤€规洖娲﹀▓鎯р攽閻樿宸ラ柛鐘宠壘宀ｅ潡鍩￠崒妯圭盎闂佸湱鍎ら崺鍫澪ｈぐ鎺撶厱鐎广儱娲﹂弳顒佹叏婵犲啯銇濇俊顐㈠暙闇夐柕澶堝劤婢э妇鈧鍠楄ぐ鍐偑娴兼潙閱囨繝闈涚墳缁遍亶姊绘担鍛靛綊鎯夋總绋跨；闁绘劗鍎ら崑鍌炴煏婢跺棙娅嗛柣鎾跺枛閺岋繝宕掑☉姗嗗殝闂佽鍨伴悧蹇涘焵椤掍胶鈯曠紒璇茬墦瀵鏁愭径瀣簻闂佸憡绺块崕鏌ュ吹閸屾粎纾藉ù锝呮惈鏍￠梺鍦嚀濞差參骞冩导鎼晪闁逞屽墮椤曪絾绂掔€ｅ灚鏅ｉ梺缁樺姈椤旀牠宕崶銊ょ箚闁绘劦浜滈埀顒佺墵楠炴劖銈ｉ崘銊э紱闂佺粯鏌ㄩ幗婊堛€呴柨瀣ㄤ簻闁哄秲鍔庨惌宀€鐥幑鎰棄闂囧鏌ㄥ┑鍡橆棞缂佽尪顕ч湁婵犲﹤鎳庢禍鍓х磼缂佹ḿ绠炲┑顔瑰亾闂佹寧绻傚Λ娑㈠Υ閹扮増鈷戦柟棰佺閻忊剝绻涢崣澶岀疄濠碉紕鏁婚獮鍥级鐠侯煈鍞洪梻浣烘嚀椤曨厽鍒婇鐐嶏綁顢涢悙绮规嫽婵炶揪绲介幊娆撳捶椤撶喎搴婂┑掳鍊曢幊搴ｅ婵犳碍鐓欓梺顓ㄧ畱閸樻挳鏌＄€ｎ偅顥堥柡灞炬礋瀹曠厧鈹戦幇顓壯囨⒑閹惰姤鏁遍柛銊ユ贡濡叉劙骞樼€涙ê顎撻柣鐘冲姦閸ㄥ磭妲愰幍顔剧＝濞达絽鎼牎闂佺粯顨堟繛鈧€殿喖顭烽弫鎰緞婵犲嫬骞愬┑鐘垫暩婵挳宕愮紒妯碱浄闁冲搫鎳忛埛鎴澝归崗鑲╂噮闁诡喖銈搁弻娑滅疀閺冩捁鈧法鈧鍣崑濠囩嵁濡偐纾兼俊顖濇〃濮规姊绘担钘変汗闁冲嘲鐗撳畷婊堟晝閳ь剙宓勬繛瀵稿帶閻°劑鍩涢幒鎳ㄥ綊鏁愰崼鐕佹婵炲瓨绮岀紞濠囧蓟瀹ュ懐鏆嬮柟娈垮枛閳敻鎮楃憴鍕缂侇喖鐭傞敐鐐测攽閸ラ鐭楀┑鐘绘涧濞诧箑鈻嶉幘缁樷拻濞达絼璀﹂弨浼存煙濞茶閭慨濠佺矙瀹曠喖顢涘鍗炲箞闂備胶顢婇幓顏堟⒔閸曨垰纾婚柨婵嗩槹閻撴洟鏌曟径妯虹仯鐎光偓濞戙垺鐓曢悗锝庡亝瀹曞矂鏌熼悡搴ｇШ妞ゃ垺娲熸俊鍫曞礋椤撶喎鐦婚梻鍌氬€搁崐鎼佸磹妞嬪海鐭嗗〒姘ｅ亾妤犵偛顦甸弫鎾绘偐閼艰埖鎲伴梻渚€娼чオ鐢碘偓闈涜嫰閳绘挻绂掔€ｎ偆鍘甸梻鍌氬€搁顓⑺囬敃鍌涚厽闁规儳顕粻鐐烘煛瀹€鈧崰鏍嵁閹达箑绠涢梻鍫熺⊕椤斿嫮绱撻崒娆掑厡濠殿垰顕槐鐐寸瑹閳ь剙顕ｆ繝姘櫜濠㈣泛锕﹂悿鈧俊鐐€栭幐楣冨窗閹惧墎鐭欓柛銉戝本瀵岄梺闈涚墕閹冲酣顢楅姀銈嗙厵闁告稑锕ラ崐鎰版煕閳哄啫浠辨鐐差儔閺佸倿鎸婃径澶嬬潖闂備浇宕垫慨鏉戔枖瑜斿畷妯款槾闁活厽顨婂濠氬磼濞嗘埈妲梺纭呭Г缁挸鐣烽幎钘壩ㄩ柍杞扮閻庮參姊洪崜鎻掍簼婵炲弶绮岄悾鍨瑹閳ь剟寮诲☉銏犵労闁告劦浜栧Σ鍫㈢磼閻愵剙鍔ら柛姘儔楠炲牓濡搁埡鍌涙珳闁硅偐琛ラ埀顒€纾鎰磽閸屾艾鈧摜绮旈幘顔芥櫇妞ゅ繐鐗忓畵渚€鏌涢幇闈涙灈闁绘挻鐩弻娑樷槈閸楃偛绠诲銈嗘煥閻倸顫忓ú顏勬嵍妞ゆ挾鍋涙俊铏圭磽娴ｇ瓔鍤欓柛濠咁潐缁岃鲸绻濋崶銊у弳闁诲函缍嗛崜娑㈡儊閸儲鈷戞慨鐟版搐閻忓弶绻涙担鍐叉閸欐挳姊婚崒娆掑厡閺嬵亝銇勯幋婵囶棦妤犵偞鍨垮畷鍫曨敆閳ь剟鎷戦悢鍏肩厽闁哄倽娉曞▓閬嶆煛鐎ｎ偅顥堥柡灞剧洴閳ワ箓骞嬪┑鍥╀憾闂備浇顕х换鎴﹀箰閸撗勵潟闁圭儤鎸堕崑鍛存煕閹板吀绨介柡鍡╁亞缁辨挻鎷呴崫鍕戯綁鏌ｅΔ鍐ㄐ㈡い鏇稻缁绘繂顫濋鐐扮盎闂佽崵鍋炵粙鍫ュ焵椤掆偓閸樻牗绔熼弴銏♀拺婵懓娲ら悘顔界箾閸涱偄鍔﹂柟顔惧厴閹囧醇閻旂儤顫栭梻鍌氬€峰ù鍥х暦閻㈢ǹ绐楅柟閭﹀枛閸ㄦ繈骞栧ǎ顒€鐏繛鍛У娣囧﹪濡堕崨顔兼闂佺ǹ顑呴崐鍧楀蓟閵娾晜鍋勯柛婵嗗珔閵忋倖鐓㈤柛鎰典簻閺嬫垹绱掔紒妯兼创妤犵偛顑呴埢搴ょ疀閺囨碍鍋呯紓鍌氬€烽懗鑸垫叏閸偆绠惧┑鐘叉搐閽冪喖鏌ㄩ悢鍝勑㈢痪鎯у悑閹便劌螣閸ф鎽甸梺姹囧妽閸ㄥ灝顫忓ú顏勪紶闁告洟娼ч崜浼存⒑閻熸澘鏆遍梺甯秮瀹曟椽鎮欓崫鍕吅闂佹寧妫佸Λ鍕焵椤掑倸鍘撮柡灞剧☉閳诲氦绠涢敐鍠帮箑鈹戦悙鍙夊珔缂傚秳绀侀～蹇曠磼濡顎撶紓浣割儓濞夋洟鎯勬惔锝囩＝濞达綀妫勯惃娲煕鐎ｎ偅灏电紒顔界濞煎繘濡歌閻﹀牓姊洪幖鐐插妧闁告粈绀侀弲顏勨攽閿涘嫬浜奸柛濠冪墪铻炲ù锝堫潐閸欏繘鏌曢崼婵囧櫝闁哄绉归弻鏇＄疀鐎ｎ亖鍋撻弽顓炵厱闁硅揪闄勯崑锝夋煙椤撶喎绗掑┑鈥冲悑缁绘盯宕ㄩ鐓庮潚闂佸搫鐬奸崰鏍х暦濞嗘挸围闁糕剝顨忔导锟�b Cardiology Department, Policlinico S. Orsola Malpighi, Bologna University, Bologna, Italy
Presented at the 55th International Congress of the European Society for Cardiovascular Surgery, St. Petersburg, Russian Federation, May 11–14, 2006.
Abstract
Objective: Atrial fibrillation (AF) is very common in patients undergoing open heart surgery. AF ablation with different sources of energy, enables the surgeon to create linear lesions rapidly and safely. However, results of these technologies need examination. We report the clinical results obtained in a 4-year experience using mono- and bipolar radiofrequency (RF) ablation of AF in a heterogeneous group of 183 patients. Methods: From May 2001 until December 2005 a total of 183 patients underwent pulmonary vein isolation using RF energy. In 73 cases, monopolar RF was used. Energy was applied in the endocardium in 40 cases (Group A) and in the epicardium in 33 cases (Group B). From May 2003, bipolar RF was used in a total of 110 patients (Group C). Duration of AF, left atrial dimensions, age or reoperations, were not considered contraindications to ablation. Ablation procedure for AF ablation was associated with a variety of cardiac procedures, from isolated mitral valve procedure to complex ascending aorta operations. Results: In-hospital mortality was 3.8% in the whole group (range 2.7–6.1%). Mortality and morbidity were not related with the ablation procedure. At the follow-up time of 50.9±3.3, 48.2±3.1, 32.7±0.9 months (Group A, B and C, respectively), sinus rhythm (SR) is present in a percentage of 75%, 67.7%, 79.4% of patients. Higher incidence of AF recurrence occurred in the first six months after surgery in all three groups. Late recurrence was higher in the epicardial group and overall freedom of AF was 64% in Group A, 46% in Group B and 71.1% in Group C (P=0.01). Conclusions: Our results demonstrate that the epicardial monopolar RF ablation obtains worse results than the endocardial monopolar RF and the bipolar RF ablation. Bipolar RF theoretically grants transmurality and is easy and safe, and a complete ablation setting lines can be achieved. Bipolar RF enables extension of ablation to every patient on AF undergoing a cardiac operation.
Key Words: Atrial fibrillation; Radiofrequency ablation; Arrhythmia
1. Introduction
The Cox-Maze procedure is the most successful surgical treatment for atrial fibrillation (AF), eliminating the arrhythmia in more than 90% of patients [1,2]. This operation has not become popular due to its complexity and invasiveness.
In recent years, it has been of increasing interest trying to simplify this procedure, using new and different energy sources to create ablation lines. In the late 1990s, unipolar radiofrequency (RF) was introduced, obtaining rate of sinus rhythm (SR) restoration, ranging from 69% to 76.9% [3–5]. Many other authors have reported similar results using monopolar RF [6–8].
Unipolar RF applications have some limitations, such as high tissue temperature, resulting in neighboring mediastinal structure damage [9] and no predictable transmurality. Recently it has been demonstrated that narrow residual gaps may conduct AF, then transmural and complete lines of ablation must be created to guarantee total block [10]. Bipolar RF devices have been designed to ensure transmurality [11,12].
In this study we report and evaluate, retrospectively, the clinical results obtained in four years of experience surgically treating AF, in three different groups of patients: Group A using endocardial monopolar RF; Group B epicardial monopolar RF; and Group C, epicardial bipolar RF. The final purpose is to identify if BP RF is superior in terms of clinical results to the monopolar RF ablation. In other words if theoretical transmurality obtained with the use of BP RF corresponds with a higher incidence of SR restoration.
2. Materials and methods
Concomitant AF treatment with RF devices was performed in 183 patients between May 2001 and December 2005. In the first 40 cases, unipolar endocardial RF was used (Group A), while in 33 cases (Group B) unipolar RF was applied on beating heart in the epicardial surface. Bipolar RF ablation was performed in 110 patients, beginning in May 2003 (Group C).
Indications for ablation were permanent AF in 93.4% patients and persistent AF in 6.5%. Demographic and preoperative data are summarized in Table 1. Duration of AF, redo, low EF, advanced age or giant left atria were not considered as contraindications. The unique exclusion criterion was emergency surgery.
Surgical indications ranged from isolated mitral valve surgery to a very complex operation. Actually, in 70 patients (38.3%), the operations performed were complex procedures: pluri-valvular surgery, ascending aorta surgery, congenital cardiopathy, etc ... BP RF ablation was also performed in addition to ventricular resynchronization in two cases and, in one of them, to a Core-Cap device implantation plus mitral valve repair. Mitral valve repair was performed in 7.1% of patients. Ablation procedure was associated with 16 reoperations (8.7% from the overall groups, 7–17.5% in Group A, 1–30% in Group B, 8–7.3% in Group C).
Informed written consent was given by each patient.
2.1. Ablation procedure
Endocardial monopolar RF ablation (Group A) was performed in 40 patients. All ablations were performed using the Cobra system (Boston Scientific Corporation, San José, California). Ablation setting was 90 W RF power for 120 s. Once the heart was arrested and the left atriotomy achieved, a semicircular ablation line, in the endocardium, was performed to isolate the right pulmonary veins. Two lines around the left pulmonary veins were made. Both encirclings were connected with an ablation line in the posterior wall of the left atrium. A connecting line from the atriotomy to the mitral valve annulus was made.
Epicardial unipolar RF ablation (Group B) was performed in 33 patients. The device used was the same as previously described. Both right and left pulmonary vein encirclings were performed on beating heart on full cardiopulmonary bypass. The connecting line in between both encirclings was made in the left atrial roof through the transverse sinus. The connecting line to the mitral valve annulus was achieved in the endocardium when left atriotomy was performed. RF was delivered for 120 s at 90 W.
Bipolar RF ablation was used in 110 patients. The ablation system used was Cobra Bipolar system (Boston Scientific Corporation, San José, California) in 102 patients (98.2%), while in the remaining patients the Cardioablate BP (Medtronic Inc., Mineanapolis, USA) was utilized. The Cobra Bipolar ablation settings were 40 W for 40 s. The Cardioablate BP was applied for 16–17 s until the transmurality was reached. Temperature as well as power were autoregulated.
After dissection of the epicardial reflection, the bipolar device was clamped around the atrial cuff containing the right pulmonary veins. On cardiopulmonary bypass and on beating heart, the heart was lifted and the left pulmonary vein's encircling were performed. Both pulmonary vein ablations are repeated twice in order to avoid gaps. On cardioplegic arrest, the left atrial appendage (LAA) was opened and an additional ablation line connecting both encirclings in the transverse sinus was performed. The line toward the mitral annulus was performed from the LAA, or from the left atriotomy when achieved in cases of mitral valve surgery.
LAA was cut off in all 183 patients, and sutured from outside with a double suture of prolene 4/0. When giant left atria was present (defined as 60 mm of anteroposterior diameter) atrial reduction plasty was performed (58 patients–31.7% of the whole group, 15 patients–45% in Group A, five patients–15.2% in Group B, 35 patients–31.8% in Group C, P=0.001).
Conduction block validation was not achieved.
2.2. Perioperative management
Amiodarone intravenous administration started before the end of cardiopulmonary bypass at a dose of 300 mg and continued for 24 h at a dose of 900–1800 mg/24 h depending on the frequency. On the second postoperative day, 150–300 mg orally was prescribed. In the case of bradycardia or A–V block, amiodarone was avoided and pacing achieved.
Early electrical cardioversion (ECV) was performed in the case of AF maintenance or recurrence.
Warfarin was stopped after three months in cases of valve repair, bioprosthesis or CABG, when SR was documented.
All patients were re-examined at three, nine months and then yearly by standard 12-lead ECG and clinical examination.
2.3. Statistics
Continuous variables were normally distributed and described by arithmetic mean±S.D. Qualitative data were presented as absolute frequencies. Univariate analyses were performed for all relevant variables by means of chi-square for categorical variables and t-test for continuous variable. Multivariate analysis was performed for variable with a P-value>0.2. One way analysis of variance was used for group comparisons. Actuarial survival was estimated by Kaplan–Meier.
3. Results
The open heart procedures are detailed in Table 2.
Cardiopulmonary bypass time was 137.8±41 min (Group A), 128±30 min (Group B) and 125±40 min (Group C) (P=0.2). Cross-clamp time was 113±33.2 (Group A), 96.9±27.6 (Group B) and 94.9±32 (Group C) (P=0.01). These very long surgical times are perfectly justified, because of the complexity of the operations. Other surgical and postoperative data are shown in Table 3.
No complication related to the ablation procedure occurred (esophageal or bronchial tree injuries). Re-exploration for bleeding was required in 5.4% (10 patients). Median ICU and hospital stay days were 2 and 15 days, respectively.
Acute renal failure was present in 6.5% (12 patients).
In-hospital mortality in Group A was 5% (two patients). Causes of death were respiratory and liver insufficiency.
In Group B a total of two patients died (6.1%). Causes of death were tamponade (high INR7) and multiorgan failure.
Early mortality in Group C was 2.7% (three patients) and causes of death were cardicac failure, left ventricle rupture in a patient with massive calcifications of the mitral valve annulus and sepsis.
At arrival in the intensive care unit 82.5%, 81.9%, 90.9% (Group A, Group B, Group C, respectively) were on sinus rhythm. During the hospital stay, 27.8%, 41.4% and 31.7% patients (%) experienced recurrence of AF (Group A, Group B, Group C, respectively). ECV was performed in all these patients. At discharge, 25%, 15.2% and 5.5% of patients (Group A, Group B, Group C, respectively) (P=0.3) were on AF, independently of full admiodarone administration and ECV.
Late follow-up was achieved in all surviving patients with an overall follow-up time of 42.8±18.9 months in Group A, 32.5±14.1 months in Group B and 17.4±10 months in Group C.
Overall incidence of SR at the end of the follow-up is 75% in Group A, 67.7% in Group B, and 79.4% in Group C (P 0.01) (Fig. 1). Late AF recurrence was identified by ECG, and it occurred in: Group A 28.6%, Group B 41.9%, and Group C 15.7% (P (A–B)=0.3, P (A–C)=0.5, P (B–C)=0.08). Overall freedom of AF for all groups was 64.9%, 46% and 71.1%, respectively (P (A–B)=0.3, P (A–C)= 0.5, P (B–C)= 0.05) (Fig. 2). These are patients who have always been on sinus rhythm from the operation until the end of the follow-up.
Of patients on SR, 40.4% were not taking any antiarrhythmic drugs. One patient required catheter ablation for atypical atrial flutter (from Group B).
Most episodes of AF recurrence occurred in the first six months, decreasing in incidence with time with the exception of Group B, which presents a marked increase of episodes even after six months. The occurrence of AF was not influenced by any preoperative data with the exception of preoperative EF: when lower than 40% is related with lower probability of SR restoration and then a higher incidence of AF recurrence (P=0.03). Of all AF recurrences, only in two cases, patients were free of antiarrhythmic therapy (all from Group C).
Oral anticoagulation therapy (OAT) was stopped in a total of 35 patients, corresponding to the 39% of patients on SR and with tissue prosthesis, or valve repair, or CABG. Cumulative time without OAT is 23.9±15.8 months.
In the follow-up, five embolic events occurred, four TIA (all patients were on OAT, 50% of them were on AF and three had a tissue bioprosthesis) and one fatal ICTUS, one month after OAT suspension, in a patient on SR and with an aortic tissue valve.
In the follow-up, a total of 11.1% in Group A, 3.2% in Group B and 2.9% in Group C required pacemaker implantation because of atrio-ventricular block or extreme bradycardia (P (A–B)=0.5, P (A–C)=0.05, P (B–C)=0.2).
4. Discussion
This report documents the mid-term results obtained with the application of radiofrequency (RF) energy for atrial fibrillation (AF) ablation in cardiac surgical patients. Three groups are compared, depending on the type of device used: unipolar or bipolar, and the approach: endocardial or epicardial.
The rationale for restoring SR in patients undergoing cardiac surgery with concomitant AF includes (1) improving survival, (2) reducing the risk of thromboembolism, (3) eliminating the need for oral anticoagulation, (4) reducing symptoms associated with high heart rate, and (5) restoring atrial contraction and then improving cardiac output [13].
The Cox-Maze procedure has evolved to become the most successful surgical treatment for AF, but because of its complexity and invasiveness has not become popular among surgeons. Thanks to the increased understanding of pathogenesis of AF and development of new ablation technologies, a great interest in surgically curing AF has occurred. Many different sources of energy have been proposed and used in different ways. However, RF (either in the monopolar version, and most recently, in the bipolar version) is the most frequently used [3,6,14–23].
Different energy sources, different lesion sets, different types of patients and surgical indications, make it difficult to identify factors which influence the rate of success/failure [7,12,23,24].
In our department we have four years experience treating AF with different modalities of RF: monopolar RF applied in the endocardial surface (Group A), in the epicardial surface (Group B) and bipolar RF (Group C). The results obtained are analyzed and compared between groups.
Our results demonstrate that restoration of SR is particularly effective using the endocardial monopolar RF ablation and the bipolar RF ablation (75% and 79.4%, respectively), while with the epicardial monopolar RF ablation the SR rates obtained are significantly lower (67.7%, P=0.01). Moreover, the recurrence of AF, being higher in the first six months after the operation in all groups, has a greater incidence in the epicardial monopolar group. Our data document that the probability of SR restoration after AF recurrence is lower in the BP group, demonstrating that in those patients whom the procedure is not immediately successful, the risk of AF maintenance is higher. Those data, however, have no statistical significance.
In our experience, we have performed the ablation procedure to each patient undergoing a cardiac operation and suffering from AF (permanent or persistent). Long duration of atrial fibrillation, dimensions of left atrium, reoperations, old age, or low EF% have not been considered as contraindication, even if that decision may be arguable for many of our colleagues. Our results demonstrate that the only predictor factor of ablation failure is the low preoperative EF (<40%), with an incidence of ablation failure of 65.3% vs. 32.1% when EF is 40% (P=0.03). The other risk factors have been evaluated and no significant correlations have been found, and multivariate analysis has not been performed. Moreover, in cases of atriomegaly, a reduction plasty of the left atrium may help ablation effectiveness.
We did not report complications related to the ablation procedure such as esophageal injuries or bronchial tree, excluding a very low incidence of atrio-ventricular block, being significantly higher in the endocardial monopolar group. The incidence of atypical flutter was very low with only one case reported and successfully treated by previous mapping, with percutaneous ablation.
We agree with Benussi et al. [25] that the high rate of recurrence of AF and other supraventricular arrhythmias, most of them in the immediate postoperative period and in the first six months, justifies the routine use of antiarrhythmic drugs for at least six months after the operation. In some cases pharmacological cardioversion may not be sufficient and electrical cardioversion (ECV) must be performed. In our experience, the higher the incidence of AF recurrence in the first six months may be related to a main etiopathology: the lack of complete fibrosis of the lesion.
In accordance with the major experts in this field [13] the ablation pattern must include the lesion toward the mitral valve annulus, and it has been always included in our patients. In the BP group (Group C), the execution of this line may be difficult, since it can be insufficient and leave a gap or, contrary, damage the circumflex artery. Our results demonstrate that, when performed correctly, the ablation line is safe and effective.
The present paper has many limitations, first of all the retrospective analysis. The patient population is markedly heterogeneous, in terms of surgical indication and procedures. That demonstrates the feasibility of the ablation procedure with RF in all the three modalities, but, at the same time, the rate of SR restoration can be conditioned by the nature of the AF and the operation performed. Moreover, when talking about AF recurrence, this can be underestimated because of no ECG verification of asymptomatic episodes. More sophisticated statistical methods would be needed to correctly estimate AF events. Another limitation is that conduction block, by pacing the pulmonary veins, has not been assessed; it is therefore possible that some patients received incomplete lesions, contributing to ablation failures. Transmurality and completeness of the lesion are not assumed, and other pathology analyses as well as postoperative catheterism would be advisable to assess these two very important factors.
We can conclude that bipolar radiofrequency is effective in curing atrial fibrillation in more than 85% of patients. Even if similar results have been obtained with the endocardial monopolar RF ablation, the BP ablation is easier to perform, is not time consuming and has a lower incidence of atrio-ventricular block as well as lower incidence of AF recurrence. Moreover, the epicardial application of the BP device allows the surgeons to extend indication to all the patients on AF (either permanent, persistent or even paroxysmal) and undergoing cardiac surgery, even in complex operations. Our results demonstrate that RF can be performed even in cases of long duration of AF, giant atrium or reoperations. The worst results obtained with the epicardial monopolar approach, in spite of the initial enthusiasm, led us to abandon that approach.
References
Prasad SM, Maniar HS, Camillo CJ, Schuessler RB, Boineau JP, Sundt III, Cox JL, Damiano J. The Cox Maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003; 126:1822–1827.
Cox JL, Boineau JP, Schuessler RB, Ferguson TB, Cain ME, Lindsay BD, Corr PB, Kater KM, Lappas DG. Successful surgical treatment of atrial fibrillation. Review and clinical update. J Am Med Assoc 1991; 266:1976–1980.
Benussi S, Pappone C, Nascimbene S, Oreto G, Caldarola A, Stefano PL, Casati V, Alfieri O. A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach. Eur J Cardiothorac Surg 2000; 17:524–529.
Melo J, Adragao P, Neves J, Ferreira M, Timoteo A, Santiago T, Ribeiras R, Canada M. Endocardial and epicardial radiofrequency ablation in the treatment of atrial fibrillation with a new intra-operative device. Eur J Cardiothorac Surg 2000; 18:182–186.
Hindricks G, Mohr FW, Autschbach R, Kottkamp H. Antiarrhythmic surgery for treatment of atrial fibrillation—new concepts. Thorac Cardiovasc Surg 1999; 47:365–369.
Hornero F, Montero JA, Canovas S, Bueno M. Biatrial radiofrequency ablation for atrial fibrillation: epicardial and endocardial surgical approach. Interact CardioVasc Thorac Surg 2002; 1:72–77.
Mohr FW, Fabricius AM, Falk V, Autschbach R, Doll N, von Oppell U, Diegeler A, Kottkamp H, Hindricks G. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results. J Thorac Cardiovasc Surg 2002; 123:919–927.
Raman JS, Ishikawa S, Power JM. Epicardial radiofrequency ablation of both atria in the treatment of atrial fibrillation: experience in patients. Ann Thorac Surg 2002; 74:1506–1509.
Aupperle H, Doll N, Walther T, Kornherr P, Ullmann C, Schoon HA, Mohr FW. Ablation of atrial fibrillation and esophageal injury: effects of energy source and ablation technique. J Thorac Cardiovasc Surg 2005; 130:1549–1554.
Melby SJ, Lee AM, Zierer A, Boineau JP, Schuessler RB, Damiano J. Do surgical ablations have to be transmural to prevent the propagation of atrial fibrillation J Am Coll Surg 2005; 201:S23.
Prasad SM, Maniar HS, Diodato MD, Schuessler RB, Damiano J. Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study. Ann Thorac Surg 2003; 76:836–842.
Gillinov AM, McCarthy PM. Atricure bipolar radiofrequency clamp for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 2002; 74:2165–2168.
Gillinov AM, McCarthy PM, Blackstone EH, Rajeswaran J, Pettersson G, Sabik JF, Svensson LG, Cosgrove DM, Hill KM, Gonzalez-Stawinski GV. Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality. J Thorac Cardiovasc Surg 2005; 129:1321–1328.
Chiappini B, Martin-Suarez S, LoForte A, Di Bartolomeo R, Marinelli G. Surgery for atrial fibrillation using radiofrequency catheter ablation. J Thorac Cardiovasc Surg 2003; 126:1788–1791.
Chiappini B, Martin-Suarez S, LoForte A, Arpesella G, Di Bartolomeo R, Marinelli G. Cox/Maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation: a comparative study. Ann Thorac Surg 2004; 77:87–92.
Benussi S, Nascimbene S, Agricola E, Calori G, Calvi S, Caldarola A, Oppizzi M, Casati V, Pappone C, Alfieri O. Surgical ablation of atrial fibrillation using the epicardial radiofrequency approach: mid-term results and risk analysis. Ann Thorac Surg 2002; 74:1050–1057.
Deneke T, Khargi K, Grewe PH, von Dryander S, Kuschkowitz F, Lawo T, Muller KM, Laczkovics A, Lemke B. Left atrial versus bi-atrial maze operation using intraoperatively cooled-tip radiofrequency ablation in patients undergoing open-heart surgery: safety and efficacy. J Am Coll Cardiol 2002; 39:1644–1650.
Gaynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, Damiano NR, Bloch JB, Moon MR, Damiano J. A prospective, single-center clinical trial of a modified Cox Maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg 2004; 128:535–542.
Melo J, Adragao P, Neves J, Ferreira MM, Pinto MM, Rebocho MJ, Parreira L, Ramos T. Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year. Eur J Cardiothorac Surg 1999; 15:851–855.
Pasic M, Bergs P, Muller P, Hofmann M, Grauhan O, Kuppe H, Hetzer R. Intraoperative radiofrequency maze ablation for atrial fibrillation: the Berlin modification. Ann Thorac Surg 2001; 72:1484–1491.
Raman J, Ishikawa S, Power J. Surgical radiofrequency ablation of both atria for the treatment of atrial fibrillation—mid term results. Heart Lung Circulation 2003; 12:A28.
Sie HT, Beukema WP, Ramdat Misier AR, Elvan A, Ennema JJ, Wellens HJJ. The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery. Eur J Cardiothorac Surg 2001; 19:443–447.
Sie HT, Beukema WP, Elvan A, Ramdat Misier AR. Long-term results of irrigated radiofrequency modified maze procedure in 200 patients with concomitant cardiac surgery: six years experience. Ann Thorac Surg 2004; 77:512–517.
Damiano J, Gaynor SL, Bailey M, Prasad S, Cox JL, Boineau JP, Schuessler RP. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. J Thorac Cardiovasc Surg 2003; 126:2016–2021.
Benussi S, Nascimbene S, Calori G, Denti P, Ziskind Z, Kassem S, La Canna G, Pappone C, Alfieri O. Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device. J Thorac Cardiovasc Surg 2005; 130:491–497.(Sofìa Martìn-Suàreza,, Barbara Claysseta)